Lin J H, Los L E, Ulm E H, Duggan D E
Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
Drug Metab Dispos. 1988 Jan-Feb;16(1):52-6.
The H2-receptor antagonists famotidine and cimetidine are both basic drugs that are predominantly eliminated by the kidneys. Cimetidine has been shown to inhibit the renal secretion of tetraethyl-ammonium bromide (TEAB) but not p-aminohippuric acid (PAH), suggesting that cimetidine is secreted by an organic cation transport system [Weiner and Roth: J. Pharmacol. Exp. Ther. 216: 516 (1981)]. The present study shows that famotidine behaves like cimetidine in that it also inhibits TEAB but not PAH excretion. Where a high concentration of cimetidine in plasma has an inhibitory effect on the renal excretion of famotidine, the reverse is not true, i.e. high plasma levels of famotidine have no effect on the excretion of cimetidine. Further evidence that additional transport systems are involved in the renal tubular secretion of cimetidine is as follows. Quinine, a potent competitor of the organic cation transport system, inhibits the secretory component of famotidine renal clearance but not that of cimetidine. Probenecid, a classic competitor for the organic anion transport system, inhibits the renal excretion of cimetidine but not famotidine. However, the effect of probenecid is minor and not sufficient to account for other components of cimetidine secretion not affected by famotidine and quinine.
H2受体拮抗剂法莫替丁和西咪替丁均为碱性药物,主要经肾脏排泄。已证实西咪替丁可抑制溴化四乙铵(TEAB)的肾脏分泌,但不影响对氨基马尿酸(PAH)的分泌,这表明西咪替丁是通过有机阳离子转运系统分泌的[维纳和罗斯:《药理学与实验治疗学杂志》216: 516(1981)]。本研究表明,法莫替丁的作用与西咪替丁相似,即它也抑制TEAB的分泌,但不影响PAH的排泄。当血浆中高浓度的西咪替丁对法莫替丁的肾脏排泄有抑制作用时,情况则相反,即血浆中法莫替丁的高浓度对西咪替丁的排泄无影响。进一步证明存在其他转运系统参与西咪替丁肾小管分泌的证据如下。奎宁是有机阳离子转运系统的强效竞争剂,它抑制法莫替丁肾脏清除率的分泌成分,但不抑制西咪替丁的分泌成分。丙磺舒是有机阴离子转运系统的经典竞争剂,它抑制西咪替丁的肾脏排泄,但不抑制法莫替丁的排泄。然而,丙磺舒的作用较小,不足以解释西咪替丁分泌中不受法莫替丁和奎宁影响的其他成分。